Personalized Genomics Market Report 2026

Personalized Genomics Market Overview

• Personalized Genomics market size has reached to $9.45 billion in 2025 • Expected to grow to $19.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.7% • Growth Driver: Rising Chronic Disease Prevalence Fueling The Growth Of The Market Due To Increasing Patient Demand For Precision Healthcare • Market Trend: Neuberg Diagnostics Launches Personalized Genomics Platform ‘Geniee’ To Enhance Health And Wellness Insights • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Genomics Market?

Personalized genomics refers to the use of an individual's genetic information to tailor medical care, lifestyle recommendations, or disease risk assessments based on their unique DNA profile. They are used for applications such as predicting disease susceptibility, optimizing drug responses, and guiding preventive healthcare strategies. The main test types of personalized genomics are oncology testing, infectious disease testing, neurological testing, cardiovascular testing, and other test types. Oncology testing involves diagnostic procedures for detecting, diagnosing, and monitoring cancer, using genetic, molecular, and imaging techniques. Technologies employed in oncology testing include polymerase chain reaction (PCR)-based tests, microarray-based tests, sequencing-based tests, and other advanced methods. These tests are applied in fields such as diagnostics, precision medicine, wellness, reproductive health, sports nutrition, lifestyle, and others, and cater to end users such as hospitals, clinics, research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.

What Is The Personalized Genomics Market Growth Forecast?

The personalized genomics market size is expected to see rapid growth in the next few years. It will grow to $19.61 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to integration of genomics into routine clinical practice, rising demand for personalized medicine, advancements in sequencing technologies, expansion of wellness and ancestry testing, growing investments by pharmaceutical and biotechnology companies. Major trends in the forecast period include rising adoption of direct-to-consumer genetic testing, growing use of pharmacogenomics in treatment planning, increasing demand for preventive and predictive healthcare, expansion of genetic testing in reproductive health, rising consumer awareness of lifestyle and wellness genomics.

Global Personalized Genomics Market Segmentation

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types 2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies 3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications 4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users Subsegments: 1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics 2) By Neurological Testing: Alzheimer's Disease Testing, Huntington’s Disease Testing, Parkinson's Disease Testing, Epilepsy Testing 3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing 4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Is The Driver Of The Personalized Genomics Market?

The rising prevalence of chronic diseases is expected to propel the growth of the personalized genomics market going forward. Chronic diseases are long-lasting conditions that require ongoing management and can include diabetes, heart disease, hypertension, and other complex health issues. The increase in chronic diseases is largely due to aging populations, sedentary lifestyles, poor diet, and environmental factors that contribute to the development of multiple conditions simultaneously. Personalized genomics supports chronic disease management by enabling large-scale genotyping and sequencing to stratify patients by genetic risk, allowing for more precise diagnostics, targeted interventions, and better prevention strategies. For instance, in April 2025, according to the U.S. Centers for Disease Control and Prevention (CDC), an US-based organization, 76.4% of U.S. adults about 194 million people had at least one of 12 selected chronic conditions, while 51.4% (around 130 million) had two or more of these conditions. Therefore, the rising prevalence of chronic diseases is driving the growth of the personalized genomics industry.

Key Players In The Global Personalized Genomics Market

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Global Personalized Genomics Market Trends and Insights

Major companies operating in the personalized genomics market are focusing on developing innovative technologies, such as personalized genomics platforms, to provide tailored insights into health, wellness, and disease prevention. A personalized genomics platform is a system that analyzes an individual's genetic data to deliver customized insights and recommendations related to health, wellness, and disease risk. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, introduced Geniee Decode Your DNA, a new customized genomics platform. It is a personalized genomics platform that offers tailored health, nutrition, and medication insights based on your genetic profile. It helps optimize wellness, prevent diseases, and personalize treatments for better health outcomes.

What Are Latest Mergers And Acquisitions In The Personalized Genomics Market?

In August 2024, Labcorp, a U.S.-based diagnostics and laboratory services company, acquired select assets of Invitae Corporation for an undisclosed amount. With this acquisition, Labcorp aims to expand its specialty testing capabilities and deepen its use of genetic data to improve clinical trials and personalized care in oncology and rare diseases. Invitae Corporation is a U.S.-based medical genetics company that specializes in comprehensive genetic testing and genomic information services.

Regional Insights

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Genomics Market?

The personalized genomics market consists of revenues earned by entities by providing services such as pharmacogenomic services, genetic counseling, and customized fitness plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized genomics market also includes sales of genetic testing kits, health risk assessments, and nutrigenomics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Genomics Market Report 2026?

The personalized genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.